nejm glp 1 SCALE (NEJM 2015) was the pivotal trial for liraglutide 3.0 mg — the first GLP-1 RA approved for chronic weight management. In 3,731 adults with obesity, it produced 8.0% mean weight loss The expanding landscape of GLP-1
Pay in 4 interest-free payments of $6.71 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 5 - Oct 10




-(1).png?sfvrsn=c236e848_3)



:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)


















